Tumor radiosensitivity and apoptosis

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 10-17

  Zhivotovsky, Boris ^a   Joseph, Bertrand ^a   Orrenius, Sten ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Radiosensitivity; Tumor cells

Indexed keywords

APOPTOSIS; CANCER CELL; CANCER RADIOTHERAPY; CANCER RESISTANCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SHORT SURVEY;

EID: 0033541417     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4452     Document Type: Article

References (80)

1. Okada S. Radiation Biochemistry. 1970;Academic Press, New York.
2. Steel G. G. Base Clinical Radiobiology. 1997;Arnold, London.
3. Kasid U., Pfeifer A., Brennan T., Beckett M., Weichselbaum R. R., Dritschilo A., Mark G. E. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science. 243:1989;1354-1356.
4. Chiarugi V., Magnelli L., Cinelli M., Turchetti A., Ruggiero M. Dominant oncogenes, tumor suppressors, and radiosensitivity. Cell. Mol. Biol. Res. 41:1995;161-166.
5. Warenius H. M., Browning P. G., Britten R. A., Peacock J. A., Rapp U. R. C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance. Eur. J. Cancer. 30A:1994;369-375.
6. Rygaard K., Slebos R. J., Spang-Thomsen M. Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenes. Int. J. Cancer. 49:1991;279-284.
7. Polischouk A. G., Scotnikova O. I., Sergeeva N. S., Zharinov G. M., Lewensohn R., Zhivotovsky B. Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the Ha-ras-1 and/or c-myc genes. Eur. J. Cancer. 33:1997;942-949.
8. Maity A., Kao G. D., Muschel R. J., McKenna W. G. Potential molecular targets for manipulating the radiation response. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;639-653.
9. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
10. Bowen I. D., Bowen S. M. Programmed Cell Death in Tumors and Tissues. 1990;Chapman and Hall, London.
11. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
12. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
13. McConkey D. J., Zhivotovsky B., Orrenius S. Apoptosis-molecular mechanisms and biomedical implications. Mol. Aspects Med. 17:1996;1-110.
14. Zhivotovsky B., Burgess D. H., Vanags D. M., Orrenius S. Involvement of cellular proteolytic machinery in apoptosis. Biochem. Biophys. Res. Commun. 230:1997;481-488.
15. Thornberry N. A., Lazebnik Y. Caspases: Enemies within. Science. 281:1998;1312-1316.
16. Yang X., Chang H. Y., Baltimore D. Autoproteolytic activation of pro-caspases by oligomerization. Mol. Cell. 1:1998;319-325.
17. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
18. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Alnemri E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
19. Reed J. C. Bcl-2 family proteins. Oncogene. 17:1998;325-336.
20. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620.
21. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B., Reed J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expressionin vitroin vivo. Oncogene. 9:1994;1799-1805.
22. Lane D. P. Cancer. p53, guardian of the genome. Nature. 358:1992;15-16.
23. Fertil B., Malaise E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 7:1981;621-629.
24. Meyn R. E., Stephens L. C., Ang K. K., Hunter N. R., Brock W. A., Milas L., Peters L. J. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64:1993;583-591.
25. Olive P. L., Durand R. E. Apoptosis: An indicator of radiosensitivityin vitro? Int. J. Radiat. Biol. 71:1997;695-707.
26. Wheeler J. A., Stephens L. C., Tornos C., Eifel P. J., Ang K. K., Milas L., Allen P. K., Meyn R. E. Jr. ASTRO Research Fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1487-1493.
27. Sirzen F., Zhivotovsky B., Nilsson A., Bergh J., Lewensohn R. Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res. 18:1998;695-699.
28. Levine E. L., Renehan A., Gossiel R., Davidson S. E., Roberts S. A., Chadwick C., Wilks D. P., Potten C. S., Hendry J. H., Hunter R. D., West C. M. L. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother. Oncol. 37:1995;1-9.
29. Dubray B., Breton C., Delic J., Klijanienko J., Maciorowski Z., Vielh P., Fourquet A., Dumont J., Magdelenat H., Cosset J. M. In vitro. Int. J. Radiat. Biol. 72:1997;759-760.
30. Aldridge D. R., Radford I. R. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 58:1998;2817-2824.
31. Sirzen F., Zhivotovsky B., Nilsson A., Bergh J., Lewenshon R. Higher spontaneous apoptotic index in small-cell compared with non-small-cell lung carcinoma cell lines: Lack of correlation with Bcl-2/Bax. Lung Cancer. 22:1998;1-13.
32. Lowe S. W., Shmitt E. M., Smith S. W., Osborne B. A., Jacks J. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
33. Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L., Wyllie A. H. Thymocytes apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
34. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
35. Chiarugi V., Magnelli L., Cinelli M. Role of p53 mutations in the radiosensitivity status of tumor cells. Tumori. 84:1998;517-520.
36. Winthrop M. D., DeNardo S. J., Muenzer J. T., Chi S. G., Gumerlock P. H. p53-independent response of a human breast carcinoma xenograft to radioimmunotherapy. Cancer. 80:1997;2529-2537.
37. Yoneda K., Yamamoto T., Osaki T. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Oral Oncol. 34:1998;529-537.
38. Sakakura C., Sweeney E. A., Shirahama T., Igarashi Y., Hakomori S., Tsujimoto H., Imanishi T., Ohgaki M., Yamazaki J., Hagiwara A., Sawai K., Yamaguchi T., Takahashi T. Overexpression of bax enhances the radiation sensitivity in human breast cancer cells. Surg. Today. 27:1997;90-93.
39. L. Blood. 89:1997;2986-2993.
40. Harima Y., Harima K., Shikata N., Oka A., Ohnishi T., Tanaka Y. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J. Cancer Res. Clin. Oncol. 124:1998;503-510.
41. Ohno T., Nakano T., Niibe Y., Tsujii H., Oka K. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma. Cancer. 83:1998;103-110.
42. Burger H., Nooter K., Boersma A. W., Kortland C. J., van den Berg A. P., Stoter G. Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;415-424.
43. Strobel T., Swanson L., Korsmeyer S., Cannistra S. A. Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells. Oncogene. 14:1997;2753-2758.
44. Peter M. E., Krammer P. H. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 10:1998;545-551.
45. Rehemtulla A., Hamilton C. A., Chinnaiyan A. M., Dixit V. M. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J. Biol. Chem. 272:1997;25783-25786.
46. Caricchio R., Reap E. A., Cohen P. L. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J. Immunol. 161:1998;241-251.
47. Aragane Y., Kulms D., Metze D., Wilkes G., Poppelmann B., Luger T. A., Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140:1998;171-182.
48. Belka C., Marini P., Budach W., Schulze-Osthoff K., Lang F., Gulbins E., Bamberg M. Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand. Radiat. Res. 149:1998;588-595.
49. Sheard M. A., Vojtesek B., Janakova L., Kovarik J., Zaloudik J. Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation. Int. J. Cancer. 73:1997;757-762.
50. Eischen C. M., Kottke T. J., Martins L. M., Basi G. S., Tung J. S., Earnshaw W. C., Leibson P. J., Kaufmann S. H. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90:1997;935-943.
51. Takahashi H., Kinouchi M., Iizuka H. Interleukin-1beta-converting enzyme and CPP32 are involved in ultraviolet B-induced apoptosis of SV40-transformed human keratinocytes. Biochem. Biophys. Res. Commun. 236:1997;194-198.
52. Bennett M., Macdonald K., Chan S. W., Luzio J. P., Simari R., Weissberg P. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis. Science. 282:1998;290-293.
53. Obeid L. M., Linardic C. M., Karolak L. A., Hannun Y. A. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
54. Kolesnick R. N., Haimovitz-Friedman A., Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72:1994;471-474.
55. Haimovitz-Friedman A., Kan C. C., Ehleiter D., Persaud R. S., McLoughlin M., Fuks Z., Kolesnick R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180:1994;525-535.
56. Wright S. C., Zheng H., Zhong J. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10:1996;325-332.
57. Santana P., Pena L. A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E. H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
58. Chmura S. J., Nodzenski E., Beckett M. A., Kufe D. W., Quintans J., Weichselbaum R. R. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1997;1270-1275.
59. Michael J. M., Lavin M. F., Watters D. J. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:1997;3600-3605.
60. Hofmann K., Dixit V. M. Ceramide in apoptosis - Does it really matter? Trends Biochem. Sci. 23:1998;374-377.
61. Saeko T. O., Oikawa S., Kawanishi S. Role of ultraviolet A-induced DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. Biochem. Biophys. Res. Commun. 247:1998;693-696.
62. Miller M. L., Andringa A., Elliott J., Conwell K. II, Dixon K., Carty M. P. The morphological and spectral phenotype of apoptosis in HeLa cells varies following exposure to UV-C and the addition of inhibitors of ICE and CPP32. Cell Prolif. 31:1998;17-33.
63. Bossy-Wetzel E., Newmeyer D. D., Green D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
64. Sheikh M. S., Antinore M. J., Huang Y., Fornace A. J. Jr. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1. Oncogene. 17:1998;2555-2563.
65. Chauhan D., Pandey P., Ogata A., Teoh G., Krett N., Halgren R., Rosen S., Kufe D., Kharbanda S., Anderson K. Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells. J. Biol. Chem. 272:1997;29995-29997.
66. Hallan E., Blomhoff H. K., Smeland E. B., Lomo J. Involvement of ICE (caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes. Scand. J. Immunol. 46:1997;601-608.
67. Yu Y., Little J. B. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58:1998;4277-4281.
68. Varfolomeev E. E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J. S., Mett I. L., Rebrikov D., Brodianski V. M., Kemper O. C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K. B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276.
69. Woo M., Hakem R., Soengas M. S., Duncan G. S., Shahinian A., Kagi D., Hakem A., McCurrach M., Khoo W., Kaufman S. A., Senaldi G., Howard T., Lowe S. W., Mak T. W. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:1998;806-819.
70. Hakem R., Hakem A., Duncan G. S., Henderson J. T., Woo M., Soengas M. S., Elia A., de la Pompa J. L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S. A., Lowe S. W., Penninger J. M., Mak T. W. Differential requirement for caspase-9 in apoptotic pathwaysin vivo. Cell. 94:1998;339-352.
71. Green D. R. Apoptotic pathways: The roads to ruin. Cell. 94:1998;695-698.
72. Fearnhead H. O., Rodriguez J., Govek E. E., Guo W., Kobayashi R., Hannon G., Lazebnik Y. A. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. USA. 95:1998;13664-13669.
73. McCurrach M. E., Connor T. M. F., Knudson C. M., Korsmeyer S. J., Lowe S. W. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;2345-2349.
74. Yin C., Knudson C. M., Korsmeyer S. J., Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosisin vivo. Nature. 385:1997;637-640.
75. Chen Q., Takeyama N., Brady G., Watson A. J. M., Dive C. Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome c can survive and maintain clonogenicity given appropriate signals to suppress apoptosis. Blood. 92:1998;4545-4553.
76. Deveraux Q. L., Takahashi R., Salvesen G. S., Reed J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:1997;300-304.
77. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
78. Ambrosini G., Adida C., Altieri D. C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:1997;917-921.
79. Tamm I., Wang Y., Sausville E., Scudiero D. A., Vigna N., Oltersdorf T., Reed J. C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58:1998;5315-5320.
80. Kawasaki H., Altieri D. C., Lu C. D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:1998;5071-5074.